The era of "oral obesity medications" has officially begun as Danish pharmaceutical company Novo Nordisk’s obesity treatment received U.S. Food and Drug Administration (FDA) approval in pill form.

While patients currently must get weekly injections of the weight loss drug Wegovy, the FDA has now approved a daily pill version of the product. After spending most of his life back and forth from ...

With Christmas only days away, Yankee Candle Village in South Deerfield may be one local spot where you can have fun and get some last-minute shopping done, all in the same place. After spending most ...

The American Academy of Pediatrics sued the U.S. Department of Health and Human Services on Wednesday, seeking to block ...

The Food and Drug Administration has approved Wegovy in pill form. Dr. Jon LaPook has the story of one man, Dr. Chris Mertens ...

Novo Nordisk A/S is rated a Buy with improved execution and valuation gap with LLY to drive outperformance through 2026. Read ...

Appetite-suppressing GLP-1 tablets become accessible in January, and manufacturers and fast-food eateries may be pushed to alter more of their goods.

Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm still bullish on LLY stock.

For the millions of Americans navigating the booming landscape of weight loss medications, the weekly injection routine just ...

Novo Nordisk's Wegovy pill is the first oral GLP-1 receptor agonist approved for weight management, offering a new treatment ...

Three inmates, all accused of violent crimes, are back in custody after escaping from an Atlanta-area jail. It’s still unclear exactly how they got out, but police say their recorded jailhouse phone ...